Neurotech Pharmaceuticals, Inc. is a private clinical stage biotech company focused on developing transformative therapies to slow the progression of Macular Telangiectasia (MacTel) and other chronic retinal diseases through its core platform technology, Encapsulated Cell Therapy (ECT).
To learn more, visit www.neurotechpharmaceuticals.com.
